| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 25.56▼ | 25.58▼ | 25.59▼ | 25.66▼ | 25.84▼ |
| MA10 | 25.58▼ | 25.63▼ | 25.66▼ | 25.66▼ | 25.88▼ |
| MA20 | 25.64▼ | 25.68▼ | 25.67▼ | 25.85▼ | 25.68▼ |
| MA50 | 25.70▼ | 25.80▼ | 25.89▼ | 25.90▼ | N/A |
| MA100 | 25.81▼ | 25.89▼ | 25.90▼ | 25.68▼ | N/A |
| MA200 | 25.87▼ | 25.81▼ | 25.74▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.010▼ | -0.005▼ | -0.031▼ | N/A |
| RSI | 28.928▼ | 29.369▼ | 30.933▼ | 38.218▼ | 48.856▼ |
| STOCH | 4.715▼ | 5.914▼ | 13.057▼ | 27.127 | 49.348 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -63.077 |
| CCI | -92.755 | -102.147▼ | -131.630▼ | -89.746 | -73.724 |
|
Monday, October 20, 2025 11:25 PM
NovaBay Pharmaceuticals (NYSE:NBY) has formally regained compliance with the NYSE American's continued listing standards, successfully resolving deficiencies first cited in April and May 2024. The ...
|
|
Wednesday, October 15, 2025 07:17 AM
Biotechnology company bioAffinity Technologies (NASDAQ:BIAF) said on Wednesday that it has regained compliance with Nasdaq's all applicable continued listing requirements. In a letter dated October 14 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 25.70 | 25.70 | 25.53 | 25.53 | 122,236 |
| 13/11/25 | 25.61 | 25.62 | 25.61 | 25.62 | 1,396 |
| 12/11/25 | 25.73 | 25.75 | 25.71 | 25.71 | 51,560 |
| 11/11/25 | 25.68 | 25.785 | 25.68 | 25.785 | 1,823 |
| 10/11/25 | 25.68 | 25.719 | 25.67 | 25.675 | 6,115 |
| 07/11/25 | 25.64 | 25.685 | 25.64 | 25.685 | 1,195 |
| 06/11/25 | 25.671 | 25.7205 | 25.671 | 25.7205 | 6,970 |
| 05/11/25 | 25.60 | 25.651 | 25.57 | 25.58 | 14,500 |
| 04/11/25 | 25.645 | 25.679 | 25.645 | 25.679 | 1,100 |
| 03/11/25 | 25.68 | 25.68 | 25.62 | 25.645 | 6,900 |
|
|
||||
|
|
||||
|
|